Plasma concentrations of orexins in children

Przemyslaw J Tomasik1, Mikolaj Spodaryk, Krystyna Sztefko

  • 1Department of Clinical Biochemistry, University Children's Hospital, Jagiellonian University, Krakow, Poland. mitomasi@cyf-kr.edu.pl

Insights

Orexin levels in children are linked to BMI and energy needs, not sleep duration. Higher orexin A and B concentrations were observed in neonates and pubertal children, with levels inversely correlating with BMI.

Area of Science:

  • Pediatric Endocrinology
  • Neuroendocrinology
  • Metabolic Research

Background:

  • Orexins are known to regulate energy balance, feeding, and arousal in animals and adults.
  • Understanding orexin roles in children is crucial for growth and metabolic health.

Purpose of the Study:

  • To evaluate plasma orexin concentrations in children across different age groups.
  • To investigate the relationship between orexin levels, Body Mass Index (BMI), energy demand, and sleep duration.

Main Methods:

  • Plasma orexin A and B concentrations were measured using Enzyme Immunoassay (EIA).
  • Samples were collected from diverse pediatric groups: newborns, infants, prepubertal, pubertal, and postpubertal adolescents.
  • Orexin levels were analyzed in relation to BMI, caloric intake, and sleep duration.

Main Results:

  • Orexin A concentrations were higher than orexin B in all children.
  • Peak orexin A and B levels were found in neonates and pubertal children.
  • A negative correlation was observed between BMI and orexin concentrations, while caloric demand showed a positive correlation.

Conclusions:

  • Orexins are significant in pediatric growth, potentially acting as long-term satiety factors.
  • Orexin signaling may coordinate energy homeostasis with pubertal development and sexual maturation.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...